Reuters |
New York accuses Insys of deceptively marketing opioid
Reuters (Reuters) - Insys Therapeutics Inc's legal woes deepened on Thursday as New York's attorney general filed a lawsuit seeking at least $75 million from the company, which he said deceptively promoted a fentanyl-based cancer pain medicine for unsafe uses ... |
February 01, 2018 at 04:58PM | marketing - Google News
New York accuses Insys of deceptively marketing opioid - Reuters
marketing - Google News
Nenhum comentário:
Postar um comentário